Switching from Intravenous to Subcutaneous Formulation of Abatacept: A Single-center Italian Experience on Efficacy and Safety

被引:13
|
作者
Reggia, Rossella [1 ,2 ]
Franceschini, Franco [1 ,2 ]
Tincani, Angela [1 ,2 ]
Cavazzana, Ilaria [1 ,2 ]
机构
[1] Spedali Civil Brescia, Rheumatol & Clin Immunol Dept, I-25125 Brescia, Italy
[2] Univ Brescia, Brescia, Italy
关键词
RHEUMATOID ARTHRITIS; THERAPY; ABATACEPT; SUBCUTANEOUS FORMULATION; EFFICACY; SAFETY; ACTIVE RHEUMATOID-ARTHRITIS; LONG-TERM SAFETY; PHASE IIIB; INADEQUATE RESPONSE; TRIAL; METHOTREXATE;
D O I
10.3899/jrheum.141042
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Subcutaneous (SC) abatacept (ABA) is comparable to intravenous (IV) formulation in terms of efficacy and safety profile. Our work analyzed the switch to SC formulation from IV administration in patients with rheumatoid arthritis. Methods. Fifty-one patients treated with SC ABA were included. Clinical data were obtained from clinical charts. Results. Fourteen patients relapsed and needed to return to the IV administration. Neither clinical and laboratory features nor the previous therapies were identified as risk factors for SC formulation inefficacy. Disease activity decreased after the return to IV infusions. Conclusion. SC ABA showed a risk of relapse in 27% of cases. The reinsertion of the IV administration quickly reinstated disease control.
引用
收藏
页码:193 / 195
页数:3
相关论文
共 50 条
  • [11] Efficacy and Safety of Duodenal Endoscopic Mucosal Resection: A Single-Center Experience
    Chaar, Abdelkader
    Frandah, Wesam
    Asad-Ur-Rahman, F. N. U.
    Siddique, Sameer
    Hawes, Robert
    Navaneethan, Udayakumar
    Varadarajulu, Shyam
    Hebert-Magee, Shantel
    Hasan, Muhammad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S170 - S170
  • [12] Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience
    Segarra, A.
    Arredondo, K. V.
    Jaramillo, J.
    Jatem, E.
    Salcedo, M. T.
    Agraz, I.
    Ramos, N.
    Carnicer, C.
    Valtierra, N.
    Ostos, E.
    LUPUS, 2020, 29 (02) : 118 - 125
  • [13] Safety and efficacy of stereoelectroencephalography in pediatric focal epilepsy: a single-center experience
    Goldstein, Hannah E.
    Youngerman, Brett E.
    Shao, Belinda
    Akman, Cigdem I.
    Mandel, Arthur M.
    McBrian, Danielle K.
    Riviello, James J.
    Sheth, Sameer A.
    McKhann, Guy M.
    Feldstein, Neil A.
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2018, 22 (04) : 444 - 452
  • [14] Efficacy and Safety of Ultrafiltration in Patients with Heart Failure: A Single-Center Experience
    Shen Xiangli
    Li Lan
    Zu Libiya
    Ma Jun
    Jiang Shubin
    Advances in Therapy, 2022, 39 : 4523 - 4532
  • [15] Real-World Study on Vedolizumab Serum Concentration, Efficacy, and Safety after the Transition from Intravenous to Subcutaneous Vedolizumab in Inflammatory Bowel Disease Patients: Single-Center Experience
    Fric, Vlasta Orsic
    Borzan, Vladimir
    Sahinovic, Ines
    Borzan, Andrej
    Kurbel, Sven
    PHARMACEUTICALS, 2023, 16 (02)
  • [16] Effectiveness of Tocilizumab after Switching from Intravenous to Subcutaneous Formulation in Patients with Rheumatoid Arthritis: A Single-Centre Experience
    Stojanovic, Sonja
    Stamenkovic, Bojana
    Nedovic, Jovan
    Aleksic, Ivana
    Cvetkovic, Jovana
    ACTA FACULTATIS MEDICAE NAISSENSIS, 2021, 38 (03) : 247 - 256
  • [17] A SINGLE CENTRE CLINICAL EXPERIENCE OF THE EFFICACY AN SAFETY PROFILE OF SUBCUTANEOUS VERSUS INTRAVENOUS BORTEZOMIB
    Randall, K.
    Qureshi, I.
    Bokhari, S.
    HAEMATOLOGICA, 2014, 99 : 636 - 637
  • [18] Abatacept as Adjunct Therapy for the Calcinosis of Juvenile Dermatomyositis: A Single-Center Experience
    DeGuzman, Marietta
    Singla, Saimun
    Mizesko, Melissa
    Sagcal-Gironella, Anna Carmela
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 136 - 137
  • [19] Long Term Efficacy and Safety of Intravenous and Subcutaneous Biologics in Large Vessels Vasculitis: 21 Patients Belonging to a Single Italian Center from 2011 to 2017
    Toniati, Paola
    Tincani, Angela
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [20] Factors associated with safety and efficacy of intravenous thrombolysis with alteplase. a ten-year single-center experience in Greece
    Papamichalis, P.
    Karagiannis, S.
    Dardiotis, E.
    Papadopoulos, D.
    Zafeiridis, T.
    Babalis, D.
    Zisopoulou, V.
    Paraforos, G.
    Hadjigeorgiou, G.
    Komnos, A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E388 - E388